Mercury Laboratories (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Mercury Laboratories Limited |
|||
|
Price: ₹881.05 (+1.27%) | ||
| 52 Week Low: ₹760.00 52 Week High: ₹1,244.00 |
|||
| Market Capital: 110.76 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Mercury Laboratories Share Price Target For 2025
- 1.1.1: Mercury Laboratories Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Mercury Laboratories Share Price Target For 2026
- 1.2.1: Mercury Laboratories Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Mercury Laboratories Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Mercury Laboratories Financial Performance
- 3.0.1: Is Mercury Laboratories A Good Buy For Long Term?
Mercury Laboratories, a Small Cap company has delivered 238.7% returns in 5-year with 59.9% profit margin, making it a potential Multibagger.
To predict the Mercury Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Mercury Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Mercury Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Mercury Laboratories shares in 2025, see the table below.
Mercury Laboratories Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 965.61 (+9.59%) | Price Action: Sep 2024 Low |
| 2025 Target 2 | 955.65 (+8.46%) | Price Action: 20 Aug 2024 High |
| 2025 Target 1 | 946.0 (+7.37%) | Price Action: 12 Nov 2024 Low |
| Current Price | 881.05 | Mercury Laboratories's share price as of 23 Jan 2025 |
| Stop Loss 1 | 848.67 (-3.68%) | Price Action: 13 Mar 2024 High |
| Stop Loss 2 | 838.11 (-4.88%) | Price Action: 23 Apr 2024 Low |
| Stop Loss 3 | 829.69 (-5.83%) | Price Action: Apr 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Mercury Laboratories is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹902.95 serves as the nearest technical reference point.
Historical Returns: 3-month: -4.99% | 6-month: -11.58% | 1-year: -28.65%
Mercury Laboratories Share Price Target For 2026
The line chart displays the monthly closing prices of Mercury Laboratories with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Mercury Laboratories shares in 2026, see the table below.
Mercury Laboratories Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1435.89 (+62.97%) | Price Action: Chart |
| 2026 Target 2 | 1409.12 (+59.93%) | Price Action: Chart |
| 2026 Target 1 | 1395.17 (+58.35%) | Fibonacci Extension Level 64.90% |
| Current Price | 881.05 | Mercury Laboratories's share price as of 23 Jan 2025 |
| Stop Loss 1 | 762.92 (-13.41%) | Price Action: 07 Nov 2023 Low |
| Stop Loss 2 | 753.36 (-14.5%) | Price Action: 14 Dec 2023 Low |
| Stop Loss 3 | 743.39 (-15.63%) | Price Action: 13 Dec 2023 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Mercury Laboratories is currently trading at 25.0% of its 52-week range (₹760 - ₹1244).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -28.65% | 3-year: +23.28% | 5-year: +238.74%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Mercury Laboratories Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹881.05 | ||
| 2025 | ₹1,183.27 | +34.3% | ₹1,201.02 |
| 2026 | ₹1,447.60 | +22.33% | ₹1,469.31 |
| 2027 | ₹2,011.29 | +38.93% | ₹2,041.46 |
| 2028 | ₹2,461.18 | +22.36% | ₹2,498.10 |
| 2029 | ₹3,098.60 | +25.89% | ₹3,145.08 |
| 2030 | ₹3,398.72 | +9.68% | ₹3,449.70 |
| 2031 | ₹3,796.63 | +11.7% | ₹3,853.58 |
| 2032 | ₹4,280.49 | +12.74% | ₹4,344.70 |
| 2033 | ₹5,021.83 | +17.31% | ₹5,097.16 |
| 2034 | ₹5,814.55 | +15.78% | ₹5,901.77 |
| 2035 | ₹6,378.39 | +9.69% | ₹6,474.07 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Mercury Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 110.76 Crore | Market valuation of Mercury Laboratories's shares. |
| Revenue (TTM) | 75.55 Crore | Total revenue generated by Mercury Laboratories over the past twelve months. |
| Net Income (TTM) | +5.65 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +9.66% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +59.89% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-3.98% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.1 | Company's total debt divided by total shareholder equity. |
| Total Debt | 5.55 Crore | Sum of Mercury Laboratories's current & long-term financial obligations. |
Is Mercury Laboratories A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
